| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
- K-Mg Aspartate
-
- $3.00
-
2019-08-08
- CAS:8076-65-1
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100kg
|
| | Magnesium potassium aspartate Basic information |
| Product Name: | Magnesium potassium aspartate | | Synonyms: | asparkam;dl-asparticacid,monopotassiumsalt,mixt.withpotassiumhydrogen(t-4)-bis(d;l-aspartato(2-)-n,o(sup1))magnesate(2-);K-Mg Aspartate;panangin;tromcardin;magnesium potassium aspartate;dl-aspartic acid magnesium-potassium salt | | CAS: | 8076-65-1 | | MF: | C8H11MgN2O8.C4H6NO4.2K | | MW: | 497.78 | | EINECS: | | | Product Categories: | | | Mol File: | 8076-65-1.mol |  |
| | Magnesium potassium aspartate Chemical Properties |
| | Magnesium potassium aspartate Usage And Synthesis |
| Description | Magnesium potassium aspartate has the following important physiological functions: participates in ornithine cycle, makes NH3 and CO2 generate urea to achieve detoxification; participates in tricarboxylic acid cycle, promotes energy metabolism, and is a catalyst for the synthesis and decomposition of high-energy phosphate compounds; Nucleotide production is an important substance for cell repair and regeneration; it can promote the excretion of bile and bile pigment, and has the effects of removing yellowish, reducing liver fat, increasing liver glycogen, etc.; promoting the development and differentiation of T lymphocytes into mature T lymphocytes, Has antiviral and antitumor effects. | | Uses | Magnesium potassium aspartate is an electrolyte supplement for the adjuvant treatment of the following diseases: acute and chronic hepatitis and liver cirrhosis, hepatic coma, drug-induced liver damage and other liver diseases. Arrhythmias in adults and children caused by various causes, hypokalemia in Chemicalbook and arrhythmia caused by digitalis poisoning, premature contractions, paroxysmal tachycardia, congestive heart failure, coronary heart disease, hypertension, tumor chemotherapy Cardiovascular diseases such as myocardial damage. | | Synthesis | 777.5g L-aspartic acid and 1.5L pure water were added into the reaction vessel, stirred well until all dissolved, then 358.7g potassium hydroxide solid (1.09eq) was added slowly while stirring, exothermic, and continued stirring after cooled to room temperature until the system was dissolved and clear, and the pH of the solution was detected to be 7.5-8.0 at room temperature (20-25v), and the solution was finely filtered by 0.45m pore size filter membrane to obtain L-aspartic acid potassium salt solution 3L. 922.6g L-aspartic acid and 2L pure water were added into the reaction vessel, heated to the internal temperature, and the L-aspartic acid potassium salt solution 3L was obtained. Filter membrane fine filtration, get L-aspartic acid potassium salt solution 3L. 922.6g L-aspartic acid and 2L pure water together added to the reaction vessel, heated to the internal temperature of 40 , stirred thoroughly and evenly until all dissolved, under the heat preservation while stirring slowly added 165.8g light magnesium oxide solid (0.59eq), exothermic, continue stirring until the system dissolved clear, cooled to room temperature (20 ~ 25 ), detection of the solution pH of 7.5 ~ 8.0 at room temperature (20 ~ 25v) ), test the solution pH was 7.5~8.0, 0.45m pore size filter membrane fine filtration, obtained L-aspartic acid magnesium salt solution 3.3 L. The above L-aspartic acid potassium salt solution and the above L-aspartic acid magnesium salt solution were added into the reaction vessel together, stirred thoroughly and homogeneously, and the pH of the system was tested to be 7.0~8.0 at room temperature (20~25 C), spray drying, obtained L-aspartic acid Potassium magnesium salt product 1.8kg. |
| | Magnesium potassium aspartate Preparation Products And Raw materials |
|